DISTINCTION BETWEEN HEPATOCELLULAR-CARCINOMA, CHOLANGIOCARCINOMA, AND METASTATIC CARCINOMA BASED ON IMMUNOHISTOCHEMICAL STAINING FOR CARCINOEMBRYONIC ANTIGEN AND FOR CYTOKERATIN-19 ON PARAFFIN SECTIONS
DISTINCTION BETWEEN HEPATOCELLULAR-CARCINOMA, CHOLANGIOCARCINOMA, AND METASTATIC CARCINOMA BASED ON IMMUNOHISTOCHEMICAL STAINING FOR CARCINOEMBRYONIC ANTIGEN AND FOR CYTOKERATIN-19 ON PARAFFIN SECTIONS
复制标题
DOI:
10.1002/path.1711560405
复制
发表时间:
1988-12-01
影响因子:
7.3
通讯作者:
BAVIERA, EE
中科院分区:
文献类型:
--
作者:
BALATON, AJ;NEHAMASIBONY, M;BAVIERA, EE
An antiserum to carcinoembryonic antigen (CEA) and a monoclonal antibody to cytokeratin 19 (CK 19) were studied for their suitability as diagnostic reagents for the differential diagnosis of primary and secondary malignant epithelial tumours of the liver, on paraffin sections. With the antiserum to CEA, positive bile canalicular structures were found in 60 per cent of the hepatocellular carcinomas. All the cholangiocarcinomas and 66.6 per cent of the metastatic carcinomas were positive for CEA, without displaying a canalicular staining pattern. All the hepatocellular carcinomas were negative for CK 19. All the cholangioceullular carcinomas and the metastatic carcinomas were positive for CK 19. This staining profile may prove helpful in difficult diagnostic cases.